Get started
Beta Bionics, Inc.Beta Bionics, Inc.Beta Bionics, Inc.

Beta Bionics, Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs
Full chart
Full chart

Compare with Beta Bionics, Inc.



Key stats


Market capitalization
‪758.89 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.51 USD
Net income (FY)
‪−73.20 M‬ USD
Revenue (FY)
‪100.25 M‬ USD
Shares float
‪33.35 M‬
Beta (1Y)
0.56

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
423
Change (1Y)
+132+45.36%
Revenue / Employee (1Y)
‪237.00 K‬ USD
Net income / Employee (1Y)
‪−173.05 K‬ USD

Profile


Sector
Health Technology
Industry
Medical Specialties
CEO
Sean Thomas Saint
Website
betabionics.com
Headquarters
Irvine
Founded
2015
IPO date
Jan 30, 2025
ISIN
US08659B1026
CUSIP
08659B102
FIGI
BBG00JNGG9Q2
Identifiers
ISIN US08659B1026
CFI code
ESVUFR
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


IWN
iShares Russell 2000 Value ETF
Weight0.04%
Market value‪6.35 M‬
IHI
iShares U.S. Medical Devices ETF
Weight0.10%
Market value‪3.21 M‬
XHE
State Street SPDR S&P Health Care Equipment ETF
Weight1.26%
Market value‪1.92 M‬
SNSR
Global X Internet of Things ETF
Weight0.37%
Market value‪852.94 K‬
VTWG
Vanguard Russell 2000 Growth ETF
Weight0.02%
Market value‪389.85 K‬
UMDV
iShares US Medical Devices UCITS ETF USD
Weight0.07%
Market value‪116.55 K‬
SGRW
Harbor Active Small Cap Growth ETF
Weight0.44%
Market value‪22.41 K‬
SNSG
Global X Internet of Things UCITS ETF USD
Weight0.37%
Market value‪9.58 K‬

Explore more ETFs 

Frequently asked questions


The current price of BBNX is 17.08 USD — it has decreased by −0.47% in the past 24 hours. Watch Beta Bionics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Beta Bionics, Inc. stocks are traded under the ticker BBNX.
BBNX stock has risen by 2.36% compared to the previous week, the month change is a 17.38% rise, over the last year Beta Bionics, Inc. has showed a 36.38% increase.
We've gathered analysts' opinions on Beta Bionics, Inc. future price: according to them, BBNX price has a max estimate of 32.00 USD and a min estimate of 13.00 USD. Watch BBNX chart and read a more detailed Beta Bionics, Inc. stock forecast: see what analysts think of Beta Bionics, Inc. and suggest that you do with its stocks.
BBNX reached its all-time high on Nov 26, 2025 with the price of 32.71 USD, and its all-time low was 8.80 USD and was reached on Apr 10, 2026. View more price dynamics on BBNX chart.
See other stocks reaching their highest and lowest prices.
BBNX stock is 8.89% volatile and has beta coefficient of 0.56. Track Beta Bionics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Beta Bionics, Inc. there?
Today Beta Bionics, Inc. has the market capitalization of ‪755.32 M‬, it has decreased by −0.36% over the last week.
Yes, you can track Beta Bionics, Inc. financials in yearly and quarterly reports right on TradingView.
Beta Bionics, Inc. is going to release the next earnings report on Jul 29, 2026. Keep track of upcoming events with our Earnings Calendar.
BBNX earnings for the last quarter are −0.49 USD per share, whereas the estimation was −0.50 USD resulting in a 2.53% surprise. The estimated earnings for the next quarter are −0.58 USD per share. See more details about Beta Bionics, Inc. earnings.
Beta Bionics, Inc. revenue for the last quarter amounts to ‪27.63 M‬ USD, despite the estimated figure of ‪26.95 M‬ USD. In the next quarter, revenue is expected to reach ‪31.56 M‬ USD.
BBNX net income for the last quarter is ‪−21.89 M‬ USD, while the quarter before that showed ‪−13.47 M‬ USD of net income which accounts for 0.00% change. Track more Beta Bionics, Inc. financial stats to get the full picture.
No, BBNX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 14, 2026, the company has 423 employees. See our rating of the largest employees — is Beta Bionics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Beta Bionics, Inc. EBITDA is ‪−74.45 M‬ USD, and current EBITDA margin is −68.63%. See more stats in Beta Bionics, Inc. financial statements.
Like other stocks, BBNX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Beta Bionics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Beta Bionics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Beta Bionics, Inc. stock shows the buy signal. See more of Beta Bionics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.